Is Cutting DEI Deadly? FDA Stops Diversity Guidance In Clinical Trials [Forbes]

Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Forbes
and Wasteful Government DEI Programs and Referencing” to terminate all “mandates, policies, programs, preferences and activities in the federal government” relating to DEI (diversity, equity and inclusion) are still taking shape, a question has been asked by some medical professionals: Can cutting DEI in medical administrations turn deadly? Over the past several days, the US Food and Drug Administration (FDA) has quietly taken down their guidance detailing Diversity Action Plans (DAPs) for clinical trials, which were set up to evaluate drugs, devices and other medical-specific products. What's the importance of diversity in clinical trials? To improve the results across a wider cross section of patient groups that have been historically
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer [Yahoo! Finance]Yahoo! Finance
- Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars [Yahoo! Finance]Yahoo! Finance
- GeminiBio Appoints Mike Stella to Board [Yahoo! Finance]Yahoo! Finance
- FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURES [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 2/4/25 - Beat
AMGN
Sec Filings
- 2/19/25 - Form 144
- 2/19/25 - Form 144
- 2/19/25 - Form 144
- AMGN's page on the SEC website